NACIONAL VISITADO REGION

Producto Participación Evolución rx Producto Participación Evolución rx

NACIONAL 15 94.1 4.3 REGION 14.3 92 9.5
ACEPTER 2.9 98.5 0.3 ACEPTER 2.9 95.1 -0.4
ACUDOPIK 5.6 100.5 1.4 ACUDOPIK 7.1 96.5 -6.3
ADEFAXIN 0.8 77.6 -1.3 ADEFAXIN 1.3 87.6 0.0
ADEPSIQUE 29.1 54.6 -17.9 ADEPSIQUE 35.8 57.4 -24.1
AKISKAM 3.8 102.8 1.2 AKISKAM 4.3 104.6 0.4
ALZAM 41.5 85.7 -2.4 ALZAM 43.4 78.2 0.5
ANAPSIQUE 99.9 100.1 0.3 ANAPSIQUE 100 100 2.2
ANEPIGRAN 2 103.9 -0.1 ANEPIGRAN 1.8 89.6 0.0
ANTREDAMIN 11.8 84.0 -4.7 ANTREDAMIN 10.8 60.5 -9.7
ARQUERA 4.5 84.2 -0.4 ARQUERA 5.6 84.5 0.7
CARBAZINA 3.4 78.4 1.3 CARBAZINA 4.2 75.5 2.8
CARBOLIT 1.6 34.5 -13.6 CARBOLIT 1.4 46.5 -12.0
CLOISONE 79.6 93.5 -3.7 CLOISONE 78.8 93.1 15.2
CLOPSINE 2 79.4 2 CLOPSINE 1.4 65 -3.4
CRIAM 8.9 108.5 0.2 CRIAM 9.6 131.5 13.8
DEPRECTAL 14.9 102.2 2 DEPRECTAL 16 107.7 -1.3
FENITRON 8.6 204.8 17.2 FENITRON 10.7 232.7 0.0
FLUOXAC 11.5 96.4 1.8 FLUOXAC 13.8 95.2 12.2
FLUPAZINE 53.6 91.2 -1.7 FLUPAZINE 54.5 85.1 32.2
GAPRIDOL 1.4 79.0 0.1 GAPRIDOL 2 88.4 0.1
HALOPERIL 28.3 112.7 0.3 HALOPERIL 33.1 107.7 -24.7
HIPOKINON 99.9 100.2 0 HIPOKINON 100 99.7 -27.0
KINESTREL 31.4 109.8 -3.7 KINESTREL 40.7 114.20 -0.6
KINEX 10.2 85.2 4.3 KINEX 9.5 90.8 -1.9
KRIADEX 22.9 106.9 7.1 KRIADEX 25.7 119.7 12.8
LEPTOPSIQUE 35.1 172.0 14.5 LEPTOPSIQUE 42.4 136.3 7.8
LIMBIK 6.1 84.7 -0.7 LIMBIK 6.3 109 -9.2
LOZAM 84 85.6 -2.6 LOZAM 83.5 87.8 -3.6
MASENNUS 21.9 93.4 -1.6 MASENNUS 20.5 94 -19.0
NOTIX 25 158.3 13.1 NOTIX 24.1 151.3 6.8
ORTOPSIQUE 14 77.5 -4.2 ORTOPSIQUE 19.5 81.6 0.8
OTEDRAM 34.3 175.3 31.4 OTEDRAM 32.4 165.5 19.6
PONTIRIDE 100 100.1 -0.2 PONTIRIDE 100 100.1 0.0
PRIDONA 82.2 101.7 4.8 PRIDONA 85.5 101.2 100.0
RAYAR 12 105.6 0.9 RAYAR 8.6 118 -0.6
REMICITAL 2.8 96.0 2 REMICITAL 3.1 95.2 0.0
SELECTIVE 5.4 100.5 -0.4 SELECTIVE 4 102.1 1.0
SERTEX 12.3 99.3 0.2 SERTEX 13.5 98.2 -5.1
TALPRAMIN 90.1 102.9 0.4 TALPRAMIN 96.6 103.6 4.9
TAMLET 10.3 111.1 0.2 TAMLET 9.9 115 10.4
TRADEA 58.6 98.9 9.9 TRADEA 52.2 85.8 5.5
TRIMOLEP 4.1 110.8 0.2 TRIMOLEP 5.7 120.3 0.0
XERENEX 10.4 97.9 -0.6 XERENEX 9.4 95.4 0.7
ZEUGIAL 0.7 94.1 0.6 ZEUGIAL 0.8 89.7 1.4
 DISTRITO
Producto Participación Evolución rx
16.2 88.6 8.4
ACEPTER 2.3 158.1 -3.0
ACUDOPIK 4.6 94.2 7.7
ADEFAXIN 1.2 73.7 0.0
ADEPSIQUE 33.5 58.6 -25.9
AKISKAM 3.8 106.9 15.0
ALZAM 46.6 75.8 1.4
ANAPSIQUE 100 99.9 -0.2
ANEPIGRAN 2.6 108.5 -4.6
ANTREDAMIN 8.9 66.7 -7.8
ARQUERA 6.1 87.6 2.3
CARBAZINA 5.7 67.3 7.9
CARBOLIT 0.8 39 -2.3
CLOISONE 70.7 94.7 -2.8
CLOPSINE 1.7 70.2 1.1
CRIAM 8 106.3 0.9
DEPRECTAL 18.9 103.7 -1.0
FENITRON 18.4 264.6 23.9
FLUOXAC 13.6 89.8 3.9
FLUPAZINE 50.9 74.1 3.1
GAPRIDOL 2.3 107.4 -3.6
HALOPERIL 48 106.2 -4.6
HIPOKINON 100 98.5 5.3
KINESTREL 44.3 109.5 6.7
KINEX 11.9 95.4 5.7
KRIADEX 27 126.3 16.3
LEPTOPSIQUE 45.8 98.9 25.7
LIMBIK 7.1 101.2 -3.0
LOZAM 84.7 90.5 -7.8
MASENNUS 17.1 82.1 7.5
NOTIX 32.3 164.8 15.7
ORTOPSIQUE 25.6 92.3 -2.5
OTEDRAM 32.2 152.1 26.5
PONTIRIDE 100 100.8 0.0
PRIDONA 85.4 100.8 21.8
RAYAR 7.8 127.2 8.3
REMICITAL 3.4 92.4 -2.0
SELECTIVE 3.7 99.4 -2.8
SERTEX 13.6 91.9 1.8
TALPRAMIN 97.8 105.7 0.0
TAMLET 10.3 127.8 -1.7
TRADEA 48.6 72.6 -0.9
TRIMOLEP 7.7 122.9 -2.0
XERENEX 11.2 89.1 0.7
ZEUGIAL 1.2 79.7 0.1
Concentrado CPC SNC
Data: ATV Febrero 2023 Rx Febrero 2023 3 4 5

MES
Región Distrito Ruta Producto Drug Market Portafolio Participación
Crecimiento portafolio
001 00103 052010303 10,287 417 4.1 -49.7
001 00103 052010303 ACEPTER 799 21 2.6 10.5
001 00103 052010303 ADEFAXIN 905 11 1.2 57.1
001 00103 052010303 ADEPSIQUE 170 2 1.2 -71.4
001 00103 052010303 ALZAM 1,143 77 6.7 -82.5
001 00103 052010303 ORTOPSIQUE 86 0 0 -100
001 00103 052010303 OTEDRAM 240 8 3.3 -85.2
001 00103 052010303 RAYAR 1,610 112 7 -2.6
001 00103 052010303 XERENEX 1,313 142 10.8 6
001 00103 052010303 ZEUGIAL 4,021 44 1.1 -6.40

SEMESTRE

Crecimiento
Ruta Producto Drug Market Portafolio Participación portafolio

Región Distrito
NACIONAL 15.0
REGIONAL 14.3
DISTRITO 103 473537 76742 16.2 -17.2
001 00103 052010303 64,449 7,084 11 -31.4
 6 9 11

TRIMESTRE SEMESTRE
Evolución Drug Market Portafolio Participación
Crecimiento portafolio Evolución Drug Market Portafolio
53.3 32,053 2,458 7.7 -46.9 53.7 64,449 7,084
124.2 2,639 69 2.6 30.2 126.7 5,207 122
207.2 3,232 25 0.8 -47.9 49 6,273 73
27.7 484 13 2.7 -97.3 5.5 1,474 494
17.8 3,621 1,212 33.5 -51.2 58.9 7,992 3,697
0 227 13 5.7 -90.7 15.2 598 153
15.6 827 196 23.7 -54 61.4 1,931 622
98.7 4,910 381 7.8 10.8 100.2 9,350 725
107.9 3,995 411 10.3 -17.6 84.9 8,113 910
97.60 12,118 138 1.1 -8 86.5 23,511 288

CUADRANTE
DE CUADRANTE CUADRANTE
DE DE
Evolución DESEMPEÑO DESEMPEÑO DESEMPEÑO
VS
NACIONAL VS REGION VS DISTRITO

94.1
92.0
88.6 cob sem dif rx
72 CRITICO CRITICO CRITICO 81.8 10.3
 14 16

SEMESTRE Cuotas
Participación
Crecimiento portafolio
Evolución Mes Trimestre Semestre
11 -31.4 72 1,781 5,278 10,429
2.3 60.5 158.1 26 82 177
1.2 -24.7 73.7 14 42 85
33.5 -62.5 58.6 271 788 1,545
46.3 -40.1 73 942 2,822 5,694
25.6 -42.5 92.3 47 128 229
32.2 44.3 152.1 109 326 589
7.8 31.6 127.2 154 429 776
11.2 -13.2 89.1 180 541 1,081
1.2 -22 79.7 38 120 253
 Coberturas Rx %
Mes Trimestre Semestre Sem Ago 22 Sem Feb 23 Diferencial
23.4 46.6 67.9 55.5 60.5 5.0
80.8 84.1 68.9 0.0 0.0 0.0
78.6 59.5 85.9 0.0 0.0 0.0
0.7 1.6 32.0 70.5 55.4 -15.2
8.2 42.9 64.9 75.7 73.0 -2.7
0.0 10.2 66.8 6.9 12.5 5.6
7.3 60.1 105.6 12.9 19.6 6.7
72.7 88.8 93.4 7.5 2.6 -4.9
78.9 76.0 84.2 11.0 23.0 12.0
115.8 115.0 113.8 3.1 4.5 1.4